Purpose: Concerns regarding anatomical anomalies and worsening neurological symptoms have prevented widespread use of epidural catheters in patients with low level spina bifida. We hypothesize that thoracic epidural placement in the T9 to T10 interspace is safe and decreases narcotic requirements following major open lower urinary tract reconstruction in patients with low level spina bifida. Materials and Methods: We reviewed consecutive patients with low level spina bifida who underwent lower urinary tract reconstruction and received epidurals for postoperative pain control. Controls were patients with low level spina bifida who received single injection transversus abdominis plane blocks and underwent similar procedures. Complications of epidural placement, including changes in motor and sensory status, were recorded. Opioid consumption was calculated using equivalent intravenous morphine doses. Mean and maximum pain scores on postoperative days 0 to 3 were calculated. Results: Ten patients with low level spina bifida who underwent lower urinary tract reconstruction with epidural were matched to 10 controls with low level spina bifida who underwent lower urinary tract reconstruction with transverse abdominis plane block. Groups were demographically similar. All patients had full abdominal sensation and functional levels at or below L3. No epidural complications or changes in neurological status were noted. The epidural group had decreased opioid consumption on postoperative days 0 to 3 (0.75 mg/kg vs 1.29 mg/kg, p ¼ 0.04). Pain scores were similar or improved in the epidural group. Conclusions: Thoracic epidural analgesia appears to be a safe and effective opioid sparing option to assist with postoperative pain management following lower urinary tract reconstruction in individuals with low level spina bifida.
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Key Words: analgesia, epidural; meningomyelocele; pediatrics; narcotics TREATMENT of postoperative pain has had significant advances due partly to increased use of regional pain block techniques. Thoracic epidural anesthesia has been shown to be beneficial in the management of postoperative pain by decreasing respiratory complications, nausea and vomiting, time until return of bowel function and length of hospital stay. 1 Although there are a few small case reports of epidural analgesia use in women with low level spina bifida during labor and delivery, 2 its use for postoperative pain management has not been studied. No direct or indirect commercial incentive associated with publishing this article.
The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number. Concern regarding anatomical anomalies and worsening neurological symptoms has prevented the use of epidural anesthesia in patients with neural tube defects. 3 Preexisting neurological conditions such as SB may set the stage for a "double crush" scenario, which maintains that patients with preexisting neural compromise may be at increased susceptibility for subsequent nerve injury from a secondary insult. 4 This scenario has historically led to recommendations not to perform regional anesthesia in this population. 5 Due to concern about pain control and inspired by accounts of success in case reports of epidural use in some women during labor and delivery, we started placing epidurals in select individuals with low level spina bifida. We sought to determine if patients who received epidural anesthesia suffered any complication related to the epidural administration or placement. The primary aim was to assess safety and the secondary aim was to assess efficacy (based on narcotic use and pain scores). We hypothesized that thoracic epidural placement in the T9 to T10 interspace in patients with LLSB is safe and patients would not be observed to have any motor or sensory changes due to the epidural placement. We further hypothesized that narcotic requirements would be decreased in patients with LLSB receiving an epidural compared to patients with LLSB undergoing similar procedures without an epidural for perioperative pain relief.
MATERIALS AND METHODS

Study Population
The study received institutional review board approval before retrospective data analysis (IRB No. 1605024102). Neurosurgeons at our institution approved placement of a thoracic epidural in select patients without evidence of thoracic disease ( fig. 1 ). All patients with LLSB (functional lesion diagnosed by developmental pediatrician based on motor function at L3 or below) undergoing LUTR with MRI demonstrating no evidence of thoracic disease were offered a thoracic epidural. Patients with LLSB without MRI in our system were excluded and were not offered epidurals. Following surgery physical and occupational therapists worked with the patients and evaluated neurological status daily as part of care.
Matching
We retrospectively reviewed consecutive patients with LLSB who underwent LUTR and received epidurals at our institution from April 2016 to October 2017. Due to the nature of lower urinary tract surgery, each patient underwent multiple procedures using 1 anesthetic. We performed a retrospective case-control study and matched these individuals to controls with LLSB based on similarity of procedures performed under the same anesthetic. Controls received single shot TAP blocks, which were placed at the end of the procedure with ultrasound guidance. Before offering epidurals TAP blocks were the current standard of care at our institution for such procedures. To ideally select our control group based on procedures, controls were recruited from a wider time frame from December 2013 to October 2017. Operative time was used as a marker for complexity of the surgery performed and was measured as time from surgery start to surgery stop.
Epidural Placement and Pain Management Strategies
All epidurals were placed in the T9 to T10 interspace after the patient was intubated and sedated ( fig. 2) . Ropivacaine 0.2% was infused at a rate of 0.4 mg/kg per hour in epidurals. This administration is in line with recommended standard pediatric epidural infusions. 5 No patient in either group was given preoperative opioid sparing analgesics. Additional opioid sparing analgesics were not administered intraoperatively in patients who received epidurals. Based on the clinical situation and surgeon and anesthesia preference, some patients who received TAP blocks also received ketorolac and/or ketamine. Patients in both groups received as needed diazepam, oral acetaminophen, ketorolac and either IV narcotics or a PCA pump based on clinical situation, surgeon preference and anesthesia preference postoperatively. No patient received gabapentin or ketamine following the procedure. PCA availability was recorded and defined as being offered or not being offered to a patient. If the patient was not offered PCA, as needed IV narcotics were available for pain relief.
Outcome Assessment
Our primary outcome was to determine the safety of epidural placement in patients with LLSB undergoing bladder reconstruction. We defined safety as not experiencing changes in neurological status. Epidural complications were defined as asymmetrical block, dural puncture, excessive block height, suboptimal analgesia, rapid onset block, spinal catheter migration, increased number of attempts/difficulty locating the epidural space and postprocedural neurological deficit. For our secondary outcome we evaluated the efficacy of the epidural by comparing opioid consumption and patient reported pain scores with and without an epidural on postoperative days 0 to 3. Opioid consumption was calculated using equivalent IV morphine doses. Pain scores were assessed by a nurse on a scale of 0 to 10 every 2 hours.
Statistical Analysis
Analysis involved Mann-Whitney U test for continuous data and Fisher exact test for categorical data. A p value of 0.05 or less was considered statistically significant (StataÒ 10.1).
RESULTS
A total of 10 patients with LLSB who underwent LUTR with epidurals placed during the study period were matched to 10 controls with LLSB who underwent similar procedures and had TAP blocks placed. Patient characteristics, including age, gender, body mass index, functional status, procedures performed, operative time, return of bowel function, number of antiemetic doses taken and length of hospital stay, were not significantly different between the 2 groups (see table) . There was no difference in VP shunt status between groups (10 in epidural group and 6 in control group, p ¼ 0.09). It is noteworthy that all patients who received an epidural had a VP shunt.
No epidural related complications or changes in neurological status were observed. All patients in both groups had functional levels at or below L3 and reported full abdominal sensation preoperatively, which was unchanged following the procedure.
The epidural group had decreased opioid consumption on postoperative days 0 to 3 (0.75 mg/kg vs 1.29 mg/kg, p ¼ 0.04). Median, mean and maximum pain scores were the same or improved in the epidural group (see table). It is noteworthy that no patient was diagnosed with any chronic pain condition and no patient was taking opioid medication before the surgical procedure.
There was no difference in postoperative complications not related to epidural placement between groups (p ¼ 0.33). In the epidural group 3 Clavien 1 complications (all Clostridium difficile colitis) and 1 Clavien 2 complication (ileus requiring total parenteral nutrition) were observed. Two patients in the control group had complications, including 1 with Clostridium difficile colitis (Clavien 1) and 1 with an ileus not requiring total parenteral nutrition, who required a blood transfusion for a slowly declining hematocrit (Clavien 2). 6 
DISCUSSION
This study represents the first known description and report of thoracic epidurals used for perioperative pain control in patients with LLSB. Most importantly, no patient in our cohort developed any change in baseline neurological function, such as motor or sensory changes, as a result of epidural placement. No complication related to epidural placement was observed. Since all patients in the epidural group had VP shunts, thoracic epidural analgesia appears safe in this cohort. Additionally those with an epidural required approximately half the narcotics of those without epidurals while reporting similar or improved pain scores.
Use of epidural anesthesia in parturients with SB has been reported but is limited to anecdotal case reports 7e13 and small case series. Most research has focused on outcomes of pregnant women with spina bifida during labor and delivery, with only 1 small case series describing epidural use for postoperative pain. 18 Overall, these series found epidural analgesia to be safe. Complications in the 52 reported epidurals have included asymmetrical There is a consensus, which is supported by our study, that if neuraxial analgesia is considered in patients with SB, the needle insertion should occur at a level above the vertebral abnormality. 3, 9 There are several limitations to our study inherent to a retrospective cohort series. First, we were unable to exactly match patients by procedure type given the individual complexity of each lower urinary tract reconstruction. However, we did match on bladder augmentation, bladder neck procedures and catheterizable bladder channel creation. Additionally the opioid and nonopioid pain and adjunct medications offered were not uniform between patients due to clinical course, surgeon or anesthesia preference. Finally, since this was a feasibility study, it was not adequately powered to evaluate for differences in other clinically relevant outcomes such as time to return of bowel function or length of hospital stay.
This study reveals the feasibility and potential benefits of thoracic epidural use in carefully selected patients with LLSB undergoing major abdominal surgery. Further research with a larger population is needed to corroborate and better evaluate other clinically relevant outcomes such as time to return of bowel function and length of hospital stay. We are currently planning a prospective trial to further evaluate the safety and potential benefit of epidural anesthesia in this patient population.
CONCLUSIONS
In appropriately selected individuals with LLSB thoracic epidural analgesia appears to be a safe and effective option to assist with opioid sparing approaches to postoperative pain management. Pain scores following LUTR are similar or decreased in patients receiving epidurals compared to TAP blocks. No epidural complications were observed.
